SEC Form 4 · accession 0001078782-19-000187
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacob Vincent Micallef
Officer — Chief Scientific Officer
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 25, 2019 | X | 11,000 | $2.20 | A | 22,000 | I | By Wife |
| Common StockF2 | holding | — | — | — | 38,113 | I | By Borlaug Limited | |
| Common Stock | holding | — | — | — | 86,166 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy)F1 | $2.20 | Feb 25, 2019 | X | 11,000 | D | Feb 26, 2014 | Feb 26, 2019 | Common Stock | 11,000 | 0 | I |
Explanation of responses
- F1The Reporting Person's wife exercised a warrant to purchase 11,000 shares of Common Stock of the issuer for $2.20 per share. The warrant was set to expire pursuant to its terms on February 26, 2019.
- F2The shares of Common Stock are held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over these shares, but disclaims beneficial ownership of the shares of Common Stock, except to the extent of his pecuniary interest therein.